GGrantIndex
← Leaderboards

Kuan Hong Wang

University Of Rochester

$5,861,974
Attributed
$11,000,404
Total exposure
5
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY201925
$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,000,404 · 5

By mechanism

R01$6,598,389 · 2
U24$2,607,802 · 1
P50$1,373,130 · 1
R21$421,083 · 1

Top collaborators

Most similar at University Of Rochester

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Neurons

Research focus

NeuronsResponseNeuromechanismInnovationMediatingAlzheimer&AposBrainBaseImageIn VivoAdultResearch Project GrantsCalciumCell TypeDementiaMeasurementFutureBrain ImagingBiological MarkersDesignImpairmentUniversitiesImmediate-Early GenesEffective Therapy

Grant awards (30)

Fronto-insular network in cognitive-affective interactions during decision-making$479,014
R01 · FY2025 · MH
Network For Emotional Wellbeing And Brain Aging (NEW Brain Aging)$595,921
U24 · FY2024 · AG
Fronto-insular network in cognitive-affective interactions during decision-making$481,589
R01 · FY2024 · MH
Bridging the translational divide from cells to patients: toward reliable neuromarkers of Batten disease$274,644
P50 · FY2024 · HD · contact PI
Network For Emotional Wellbeing And Brain Aging (NEW Brain Aging)$35,035
U24 · FY2024 · AG
Mechanism and Optimization of CBD-mediated analgesic effects$670,866
R01 · FY2023 · AT
Network For Emotional Wellbeing And Brain Aging (NEW Brain Aging)$602,109
U24 · FY2023 · AG
Fronto-insular network in cognitive-affective interactions during decision-making$484,279
R01 · FY2023 · MH
Fronto-insular network in cognitive-affective interactions during decision-making$377,338
R01 · FY2023 · MH
Mechanism and optimization of CBD-mediated analgesic effects (Admin Supplement)$339,856
R01 · FY2023 · AT
Bridging the translational divide from cells to patients: toward reliable neuromarkers of Batten disease$274,554
P50 · FY2023 · HD · contact PI
High-resolution multi-modal ultrasound imaging of brain development in Batten disease models$191,274
R21 · FY2023 · EB
Mechanism and optimization of CBD-mediated analgesic effects (Admin Supplement)$74,671
R01 · FY2023 · AT
Network For Emotional Wellbeing And Brain Aging (NEW Brain Aging)$70,270
U24 · FY2023 · AG
Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement)$50,242
R01 · FY2023 · AT
Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement)$28,201
R01 · FY2023 · AT
Mechanism and Optimization of CBD-mediated analgesic effects$670,866
R01 · FY2022 · AT
Network For Emotional Wellbeing And Brain Aging (NEW Brain Aging)$610,391
U24 · FY2022 · AG
Fronto-insular network in cognitive-affective interactions during decision-making$513,164
R01 · FY2022 · MH
Bridging the translational divide from cells to patients: toward reliable neuromarkers of Batten disease$274,644
P50 · FY2022 · HD · contact PI
High-resolution multi-modal ultrasound imaging of brain development in Batten disease models$229,809
R21 · FY2022 · EB
U24 NEW Brain Aging Diversity Supplement$35,035
U24 · FY2022 · AG
Mechanism and Optimization of CBD-mediated analgesic effects$670,866
R01 · FY2021 · AT
Network For Emotional Wellbeing And Brain Aging (NEW Brain Aging)$659,041
U24 · FY2021 · AG
Bridging the translational divide from cells to patients: toward reliable neuromarkers of Batten disease$274,644
P50 · FY2021 · HD · contact PI
Mechanism and Optimization of CBD-mediated analgesic effects$264,303
R01 · FY2021 · AT
Mechanism and Optimization of CBD-mediated analgesic effects$132,152
R01 · FY2021 · AT
Mechanism and Optimization of CBD-mediated analgesic effects$670,866
R01 · FY2020 · AT
Bridging the translational divide from cells to patients: toward reliable neuromarkers of Batten disease$274,644
P50 · FY2020 · HD · contact PI
Mechanism and Optimization of CBD-mediated analgesic effects$690,116
R01 · FY2019 · AT